Dexuan Xiao

2.1k total citations · 2 hit papers
46 papers, 1.7k citations indexed

About

Dexuan Xiao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Dexuan Xiao has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Dexuan Xiao's work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (17 papers) and MicroRNA in disease regulation (7 papers). Dexuan Xiao is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (17 papers) and MicroRNA in disease regulation (7 papers). Dexuan Xiao collaborates with scholars based in China, United States and Myanmar. Dexuan Xiao's co-authors include Yunfeng Lin, Mei Zhang, Taoran Tian, Xiaoxiao Cai, Yanjing Li, Weitong Cui, Junyao Zhu, Shaojingya Gao, Sirong Shi and Xin Qin and has published in prestigious journals such as Nano Letters, Biomaterials and Advanced Functional Materials.

In The Last Decade

Dexuan Xiao

45 papers receiving 1.7k citations

Hit Papers

Anti-inflammatory activity of curcumin-loaded tetrahedral... 2021 2026 2022 2024 2021 2022 50 100 150

Peers

Dexuan Xiao
Dexuan Xiao
Citations per year, relative to Dexuan Xiao Dexuan Xiao (= 1×) peers Weitong Cui

Countries citing papers authored by Dexuan Xiao

Since Specialization
Citations

This map shows the geographic impact of Dexuan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dexuan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dexuan Xiao more than expected).

Fields of papers citing papers by Dexuan Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dexuan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dexuan Xiao. The network helps show where Dexuan Xiao may publish in the future.

Co-authorship network of co-authors of Dexuan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Dexuan Xiao. A scholar is included among the top collaborators of Dexuan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dexuan Xiao. Dexuan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Tianyu, Mengxi Yang, Yuhuan Jiang, et al.. (2025). Treatment of atherosclerosis by biomimetic responsive-targeting hybrid nanoparticles enabled by genetically engineering cell membranes and nucleic acid nanostructures for atorvastatin delivery. Chemical Engineering Journal. 511. 162130–162130. 2 indexed citations
2.
Zhou, Mi, Tianxu Zhang, Dexuan Xiao, et al.. (2025). A DNA-based nanorobot for targeting, hitchhiking, and regulating neutrophils to enhance sepsis therapy. Biomaterials. 318. 123183–123183. 18 indexed citations
3.
Sun, Qiang, Dexuan Xiao, Mei Zhang, et al.. (2024). Tetrahedral framework nucleic acids/hyaluronic acid-methacrylic anhydride hybrid hydrogel with antimicrobial and anti-inflammatory properties for infected wound healing. International Journal of Oral Science. 16(1). 30–30. 49 indexed citations
5.
Xiao, Dexuan, Tianyu Chen, Tianxu Zhang, et al.. (2023). Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters. 35(4). 108602–108602. 9 indexed citations
6.
Chen, Tianyu, et al.. (2023). Application and prospects of nucleic acid nanomaterials in tumor therapy. RSC Advances. 13(37). 26288–26301. 6 indexed citations
7.
Shi, Sirong, et al.. (2023). Amelioration of Osteoarthritis via Tetrahedral Framework Nucleic Acids Delivering Microrna‐124 for Cartilage Regeneration. Advanced Functional Materials. 33(46). 36 indexed citations
8.
Zhao, Dan, Dexuan Xiao, Mengting Liu, et al.. (2022). Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis. International Journal of Oral Science. 14(1). 23–23. 42 indexed citations
9.
Yao, Yangxue, Yuting Wen, Yanjing Li, et al.. (2021). Tetrahedral framework nucleic acids facilitate neurorestoration of facial nerves by activating the NGF/PI3K/AKT pathway. Nanoscale. 13(37). 15598–15610. 18 indexed citations
10.
Li, Yanjing, Shaojingya Gao, Sirong Shi, et al.. (2021). Tetrahedral Framework Nucleic Acid-Based Delivery of Resveratrol Alleviates Insulin Resistance: From Innate to Adaptive Immunity. Nano-Micro Letters. 13(1). 186–186. 63 indexed citations
11.
Zhang, Mei, Xiaolin Zhang, Taoran Tian, et al.. (2021). Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioactive Materials. 8. 368–380. 189 indexed citations breakdown →
12.
Peng, Shuanglin, Sirong Shi, Gang Tao, et al.. (2021). JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation. Stem Cell Research & Therapy. 12(1). 120–120. 22 indexed citations
13.
Gao, Shaojingya, Yun Wang, Yanjing Li, et al.. (2021). Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren’s Syndrome Mouse Model. ACS Applied Materials & Interfaces. 13(36). 42543–42553. 18 indexed citations
14.
Li, Qirong, Ronghui Zhou, Yue Sun, et al.. (2021). Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters. ACS Applied Materials & Interfaces. 13(10). 11708–11720. 17 indexed citations
15.
Zhang, Tianxu, Yang Gao, Weitong Cui, et al.. (2020). Nanomaterials-based Cell Osteogenic Differentiation and Bone Regeneration. Current Stem Cell Research & Therapy. 16(1). 36–47. 13 indexed citations
16.
Gao, Yang, Tianxu Zhang, Junyao Zhu, et al.. (2020). Effects of the tetrahedral framework nucleic acids on the skeletal muscle regeneration in vitro and in vivo. Materials Chemistry Frontiers. 4(9). 2731–2743. 11 indexed citations
17.
Zhou, Ronghui, Yanjing Li, Dexuan Xiao, et al.. (2020). Hyaluronan-directed fabrication of co-doped hydroxyapatite as a dual-modal probe for tumor-specific bioimaging. Journal of Materials Chemistry B. 8(10). 2107–2114. 19 indexed citations
18.
Zhu, Junyao, Mei Zhang, Yang Gao, et al.. (2020). Tetrahedral framework nucleic acids promote scarless healing of cutaneous wounds via the AKT-signaling pathway. Signal Transduction and Targeted Therapy. 5(1). 120–120. 94 indexed citations
19.
Zhang, Tianxu, Yang Gao, Dexuan Xiao, et al.. (2020). Nucleic acid based tetrahedral framework DNA nanostructures for fibrotic diseases therapy. Applied Materials Today. 20. 100725–100725. 14 indexed citations
20.
Zhang, Mei, Junyao Zhu, Xin Qin, et al.. (2019). Cardioprotection of Tetrahedral DNA Nanostructures in Myocardial Ischemia-Reperfusion Injury. ACS Applied Materials & Interfaces. 11(34). 30631–30639. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026